74 related articles for article (PubMed ID: 32295782)
1. Loss of BAP1 Leads to More YAPing in Pancreatic Cancer.
Brekken RA
Cancer Res; 2020 Apr; 80(8):1624-1625. PubMed ID: 32295782
[TBL] [Abstract][Full Text] [Related]
2. The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma.
Lee HJ; Pham T; Chang MT; Barnes D; Cai AG; Noubade R; Totpal K; Chen X; Tran C; Hagenbeek T; Wu X; Eastham-Anderson J; Tao J; Lee W; Bastian BC; Carbone M; Webster JD; Dey A
Cancer Res; 2020 Apr; 80(8):1656-1668. PubMed ID: 31988076
[TBL] [Abstract][Full Text] [Related]
3. Loss of BAP1 Expression Is Very Rare in Pancreatic Ductal Adenocarcinoma.
Tayao M; Andrici J; Farzin M; Clarkson A; Sioson L; Watson N; Chua TC; Sztynda T; Samra JS; Gill AJ
PLoS One; 2016; 11(3):e0150338. PubMed ID: 26982343
[TBL] [Abstract][Full Text] [Related]
4. Nuclear BAP1 loss is common in intrahepatic cholangiocarcinoma and a subtype of hepatocellular carcinoma but rare in pancreatic ductal adenocarcinoma.
Mosbeh A; Halfawy K; Abdel-Mageed WS; Sweed D; Rahman MHA
Cancer Genet; 2018 Aug; 224-225():21-28. PubMed ID: 29778232
[TBL] [Abstract][Full Text] [Related]
5. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
6. [Role of Hippo Signaling Pathway in Lung Cancer].
Liu Y; Xing Y; Cai L
Zhongguo Fei Ai Za Zhi; 2017 Sep; 20(9):629-634. PubMed ID: 28935017
[TBL] [Abstract][Full Text] [Related]
7. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
8. A role for ATM in hereditary pancreatic cancer.
Bakker JL; de Winter JP
Cancer Discov; 2012 Jan; 2(1):14-5. PubMed ID: 22585162
[TBL] [Abstract][Full Text] [Related]
9. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway.
Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z
Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921
[TBL] [Abstract][Full Text] [Related]
10. Loss of BRCA1-associated protein 1 (BAP1) expression is rare in non-small cell lung cancer.
Owen D; Sheffield BS; Ionescu D; Churg A
Hum Pathol; 2017 Feb; 60():82-85. PubMed ID: 27984124
[TBL] [Abstract][Full Text] [Related]
11. Bap1 is essential for kidney function and cooperates with Vhl in renal tumorigenesis.
Wang SS; Gu YF; Wolff N; Stefanius K; Christie A; Dey A; Hammer RE; Xie XJ; Rakheja D; Pedrosa I; Carroll T; McKay RM; Kapur P; Brugarolas J
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16538-43. PubMed ID: 25359211
[TBL] [Abstract][Full Text] [Related]
12. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins.
Nguyen HT; Kugler JM; Cohen SM
PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504
[TBL] [Abstract][Full Text] [Related]
13. Cell-intrinsic PD-1 promotes proliferation in pancreatic cancer by targeting CYR61/CTGF via the hippo pathway.
Pu N; Gao S; Yin H; Li JA; Wu W; Fang Y; Zhang L; Rong Y; Xu X; Wang D; Kuang T; Jin D; Yu J; Lou W
Cancer Lett; 2019 Sep; 460():42-53. PubMed ID: 31233838
[TBL] [Abstract][Full Text] [Related]
14. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
[TBL] [Abstract][Full Text] [Related]
15. Tumor Suppression by p53: Bring in the Hippo!
Aylon Y; Oren M
Cancer Cell; 2017 Oct; 32(4):397-399. PubMed ID: 29017051
[TBL] [Abstract][Full Text] [Related]
16. Two Birds with One Stone: Therapeutic Targeting of IL1α Signaling Pathways in Pancreatic Ductal Adenocarcinoma and the Cancer-Associated Fibroblasts.
Ling J; Chiao PJ
Cancer Discov; 2019 Feb; 9(2):173-175. PubMed ID: 30737215
[TBL] [Abstract][Full Text] [Related]
17. BAP1: case report and insight into a novel tumor suppressor.
Ghosh K; Modi B; James WD; Capell BC
BMC Dermatol; 2017 Nov; 17(1):13. PubMed ID: 29166932
[TBL] [Abstract][Full Text] [Related]
18. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
Shen C; Wang Y; Wei P; Du X
BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
[TBL] [Abstract][Full Text] [Related]
19. Different prognostic roles of tumor suppressor gene BAP1 in cancer: A systematic review with meta-analysis.
Luchini C; Veronese N; Yachida S; Cheng L; Nottegar A; Stubbs B; Solmi M; Capelli P; Pea A; Barbareschi M; Fassan M; Wood LD; Scarpa A
Genes Chromosomes Cancer; 2016 Oct; 55(10):741-9. PubMed ID: 27223342
[TBL] [Abstract][Full Text] [Related]
20. Roles of RUNX in Hippo Pathway Signaling.
Passaniti A; Brusgard JL; Qiao Y; Sudol M; Finch-Edmondson M
Adv Exp Med Biol; 2017; 962():435-448. PubMed ID: 28299672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
